Teladoc’s blockbuster merger with Livongo in 2020 would’ve been unthinkable just a few years ago.
Health technology companies didn’t typically command enormous valuations, and they certainly didn’t sell for $18.5 billion.
The deal’s timing, in the depths of the pandemic, wasn’t just fortuitous for Livongo and Teladoc shareholders. Rather, it set the stage for a wave of mergers and acquisitions that have ultimately ushered in a new era in virtual care. While the particulars of the new digital health landscape are still being hammered out, one thing is clear: employers, patients, and clinicians have had enough with narrow, point solutions. The time for virtual-first, comprehensive care is here, a group of executives, investors, and analysts told STAT.
About the Author Reprints
To submit a correction request, please visit our Contact Us page.
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect